- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/47 - QuinolinesIsoquinolines
Patent holdings for IPC class A61K 31/47
Total number of patents in this class: 5287
10-year publication summary
|
303
|
278
|
318
|
317
|
330
|
341
|
305
|
254
|
276
|
40
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Vertex Pharmaceuticals Incorporated | 1623 |
128 |
| Exelixis, Inc. | 397 |
108 |
| Eisai R&D Management Co., Ltd. | 1192 |
82 |
| Aldeyra Therapeutics, Inc. | 104 |
58 |
| Janssen Pharmaceutica N.V. | 3322 |
49 |
| Centre National de La Recherche Scientifique | 10802 |
49 |
| Bristol-myers Squibb Company | 4809 |
46 |
| The Regents of the University of California | 20366 |
44 |
| Merck Sharp & Dohme LLC | 3748 |
39 |
| Abivax | 120 |
37 |
| Taisho Pharmaceutical Co., Ltd. | 863 |
33 |
| Institut Curie | 603 |
32 |
| Merck Sharp & Dohme Corp. | 2186 |
31 |
| Boehringer Ingelheim International GmbH | 4587 |
27 |
| Universite de Montpellier | 1025 |
27 |
| Shenzhen Chipscreen Biosciences Co., Ltd. | 90 |
26 |
| F. Hoffmann-La Roche AG | 7881 |
25 |
| Jiangsu Yahong Meditech Co., Ltd. | 67 |
25 |
| Novartis AG | 10481 |
24 |
| Gilead Sciences, Inc. | 2136 |
24 |
| Other owners | 4373 |